AngioDynamics Stock Price, News & Analysis (NASDAQ:ANGO)

$16.99 -0.23 (-1.34 %)
(As of 12/15/2017 10:58 AM ET)
Previous Close$17.22
Today's Range$16.96 - $17.41
52-Week Range$14.80 - $18.85
Volume270,400 shs
Average Volume233,531 shs
Market Capitalization$632.24 million
P/E Ratio24.96
Dividend YieldN/A
Beta1.04

About AngioDynamics (NASDAQ:ANGO)

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Debt-to-Equity Ratio0.17%
Current Ratio2.34%
Quick Ratio1.48%

Price-To-Earnings

Trailing P/E Ratio24.96
Forward P/E Ratio26.14
P/E Growth1.77

Sales & Book Value

Annual Sales$349.64 million
Price / Sales1.78
Cash Flow$1.39 per share
Price / Cash12.22
Book Value$14.00 per share
Price / Book1.21

Profitability

Trailing EPS$0.15
Net Income$5 million
Net Margins1.64%
Return on Equity4.83%
Return on Assets3.57%

Miscellaneous

Employees1,250
Outstanding Shares36,720,000

AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) issued its quarterly earnings results on Thursday, September, 28th. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.16 by $0.04. The medical instruments supplier had revenue of $85.40 million for the quarter, compared to analysts' expectations of $86.12 million. AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The company's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.17 EPS. View AngioDynamics' Earnings History.

When will AngioDynamics make its next earnings announcement?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Thursday, January, 4th 2018. View Earnings Estimates for AngioDynamics.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics updated its FY18 earnings guidance on Thursday, September, 28th. The company provided earnings per share (EPS) guidance of $0.64-0.68 for the period, compared to the Thomson Reuters consensus estimate of $0.67. The company issued revenue guidance of $352-359 million, compared to the consensus revenue estimate of $355.58 million.

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2017?

5 brokers have issued 1 year price targets for AngioDynamics' shares. Their forecasts range from $16.00 to $21.00. On average, they expect AngioDynamics' share price to reach $18.50 in the next year. View Analyst Ratings for AngioDynamics.

What are Wall Street analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • 1. According to Zacks Investment Research, "AngioDynamics reported a dismal first quarter of fiscal 2018 wherein adjusted earnings and revenues missed the Zacks Consensus Estimate. The company reaffirmed its guidance for fiscal 2018. AngioDynamicis rides on the market’s solid response to Solero, especially within the Microwave Ablation space. Growth in the core Angiographic Catheter business is also likely to fortify the company’s footprint in the global space. On the flipside, AngioDynamics recalled the Acculis Microwave Tissue Ablation System under the Oncology and Surgery segment last quarter. The company also had a high outstanding debt level at the end of the first quarter. Higher debts impose certain operating and financial restrictions which might limit the execution of the company’s core business strategies. AngioDynamics traded below the broader industry in the past year." (10/3/2017)
  • 2. Cantor Fitzgerald analysts commented, "F3Q17 Result Summary. F3Q17 total revenues of $85.6M (down 2.0% y/y), was $3.2M below our estimate of $88.8M and $2.7M below FactSet consensus of $88.3M." (3/30/2017)

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:

  • Howard W. Donnelly, Independent Chairman of the Board (Age 56)
  • James C. Clemmer, President, Chief Executive Officer, Director (Age 53)
  • Michael C. Greiner, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 44)
  • Robert A. Simpson, Senior Vice President and General Manager, Peripheral Vascular (Age 45)
  • Heather J. Daniels-Cariveau, Senior Vice President of Human Resources (Age 43)
  • Gary Barrett, Senior Vice President,Quality and Regulatory Affairs (Age 47)
  • Chad T. Campbell, Senior Vice President and General Manager, Vascular Access (Age 46)
  • Benjamin Davis, Senior Vice President, Business Development (Age 52)
  • Barbara A. Kucharczyk, Senior Vice President-Global Operations (Age 44)
  • Warren G. Nighan, Senior Vice President-Senior Vice President Quality & Regulatory Affairs (Age 48)

Who owns AngioDynamics stock?

AngioDynamics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.40%), Janus Henderson Group PLC (3.92%), Wells Fargo & Company MN (2.79%), Royce & Associates LP (2.63%), Ameriprise Financial Inc. (1.74%) and Peregrine Capital Management LLC (1.50%). Company insiders that own AngioDynamics stock include Avista Capital Partners Gp, Ll, Charles R Greiner, David F Burgstahler, James C Clemmer, Jan Stern Reed and Stephen A Trowbridge. View Institutional Ownership Trends for AngioDynamics.

Who sold AngioDynamics stock? Who is selling AngioDynamics stock?

AngioDynamics' stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Systematic Financial Management LP, Cornerstone Capital Management Holdings LLC., First Quadrant L P CA, Bank of New York Mellon Corp, Dimensional Fund Advisors LP, Prudential Financial Inc. and Ameriprise Financial Inc.. View Insider Buying and Selling for AngioDynamics.

Who bought AngioDynamics stock? Who is buying AngioDynamics stock?

AngioDynamics' stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Foundry Partners LLC, Thomson Horstmann & Bryant Inc., OxFORD Asset Management LLP, Municipal Employees Retirement System of Michigan, Candriam Luxembourg S.C.A., First Trust Advisors LP and American Century Companies Inc.. Company insiders that have bought AngioDynamics stock in the last two years include James C Clemmer and Jan Stern Reed. View Insider Buying and Selling for AngioDynamics.

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of AngioDynamics stock can currently be purchased for approximately $16.99.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $632.24 million and generates $349.64 million in revenue each year. The medical instruments supplier earns $5 million in net income (profit) each year or $0.15 on an earnings per share basis. AngioDynamics employs 1,250 workers across the globe.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]


MarketBeat Community Rating for AngioDynamics (ANGO)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  128 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  336
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AngioDynamics (NASDAQ:ANGO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.402.402.332.50
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.40$18.40$17.33$17.42
Price Target Upside: 8.04% upside8.04% upside3.85% upside15.50% upside

AngioDynamics (NASDAQ:ANGO) Consensus Price Target History

Price Target History for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ:ANGO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/8/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
9/29/2017KeyCorpReiterated RatingHoldHighView Rating Details
7/19/2017BarclaysLower Price TargetEqual Weight$17.00 -> $16.00LowView Rating Details
7/4/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 -> $21.00LowView Rating Details
4/1/2017Craig HallumSet Price TargetBuy$20.00LowView Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00N/AView Rating Details
(Data available from 12/15/2015 forward)

Earnings

AngioDynamics (NASDAQ:ANGO) Earnings History and Estimates Chart

Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ ANGO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/4/2018$0.16N/AView Earnings Details
9/28/2017Q1 2018$0.16$0.12$86.12 million$85.40 millionViewN/AView Earnings Details
7/18/2017Q4 2017$0.16$0.19$90.72 million$86.90 millionViewN/AView Earnings Details
3/30/2017Q3 2017$0.15$0.19$88.29 million$85.60 millionViewN/AView Earnings Details
1/6/2017Q217$0.16$0.19$91.09 million$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$86.09 million$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$85.43 million$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$84.70 million$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.15$0.12$88.69 million$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$85.35 million$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

AngioDynamics (NASDAQ:ANGO) Earnings Estimates

2017 EPS Consensus Estimate: $0.61
2018 EPS Consensus Estimate: $0.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.13$0.13$0.13
Q2 20171$0.17$0.17$0.17
Q3 20172$0.15$0.16$0.16
Q4 20172$0.14$0.16$0.15
Q1 20182$0.14$0.18$0.16
Q2 20182$0.15$0.16$0.16
Q3 20182$0.18$0.23$0.21
Q4 20182$0.15$0.23$0.19
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

AngioDynamics (NASDAQ ANGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.80%
Institutional Ownership Percentage: 95.29%
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ ANGO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/24/2017Jan Stern ReedDirectorBuy316$16.00$5,056.00View SEC Filing  
7/21/2017James C ClemmerCEOBuy5,000$15.79$78,950.00View SEC Filing  
7/20/2017James C ClemmerCEOBuy20,000$15.64$312,800.00View SEC Filing  
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00View SEC Filing  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AngioDynamics (NASDAQ ANGO) News Headlines

Source:
DateHeadline
AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
finance.yahoo.com - December 12 at 11:59 AM
$0.17 EPS Expected for AngioDynamics, Inc. (ANGO) This Quarter$0.17 EPS Expected for AngioDynamics, Inc. (ANGO) This Quarter
www.americanbankingnews.com - December 11 at 7:14 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017
finance.yahoo.com - December 5 at 12:59 PM
 Brokerages Anticipate AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million Brokerages Anticipate AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million
www.americanbankingnews.com - November 25 at 2:14 AM
AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : November 24, 2017AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : November 24, 2017
finance.yahoo.com - November 24 at 11:44 AM
Zacks: Brokerages Expect AngioDynamics, Inc. (ANGO) Will Post Earnings of $0.17 Per ShareZacks: Brokerages Expect AngioDynamics, Inc. (ANGO) Will Post Earnings of $0.17 Per Share
www.americanbankingnews.com - November 23 at 11:16 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017
finance.yahoo.com - November 22 at 4:27 PM
AngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Hold" by BrokeragesAngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 20 at 5:44 PM
$88.61 Million in Sales Expected for AngioDynamics, Inc. (ANGO) This Quarter$88.61 Million in Sales Expected for AngioDynamics, Inc. (ANGO) This Quarter
www.americanbankingnews.com - November 6 at 2:32 AM
Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report?Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report?
finance.yahoo.com - October 30 at 4:48 PM
ETFs with exposure to AngioDynamics, Inc. : October 27, 2017ETFs with exposure to AngioDynamics, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 6:06 PM
AngioDynamics, Inc. (ANGO) Receives Consensus Rating of "Hold" from BrokeragesAngioDynamics, Inc. (ANGO) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - October 26 at 9:38 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017
finance.yahoo.com - October 17 at 4:43 PM
 Analysts Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share Analysts Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share
www.americanbankingnews.com - October 16 at 6:24 AM
AngioDynamics, Inc. (ANGO) Earns "Hold" Rating from Canaccord GenuityAngioDynamics, Inc. (ANGO) Earns "Hold" Rating from Canaccord Genuity
www.americanbankingnews.com - October 9 at 3:16 PM
Earnings Review and Free Research Report: Lakeland’s Revenue Jumped 7.4%; EPS Surged 25%Earnings Review and Free Research Report: Lakeland’s Revenue Jumped 7.4%; EPS Surged 25%
finance.yahoo.com - October 4 at 2:21 PM
AngioDynamicis' (ANGO) Solero MTA System to Drive GrowthAngioDynamicis' (ANGO) Solero MTA System to Drive Growth
finance.yahoo.com - October 4 at 2:21 PM
ETFs with exposure to AngioDynamics, Inc. : October 4, 2017ETFs with exposure to AngioDynamics, Inc. : October 4, 2017
finance.yahoo.com - October 4 at 2:21 PM
AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017
finance.yahoo.com - October 3 at 3:39 PM
AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : October 2, 2017AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : October 2, 2017
finance.yahoo.com - October 2 at 3:46 PM
Research Analysts Set Expectations for AngioDynamics, Inc.s Q2 2018 Earnings (ANGO)Research Analysts Set Expectations for AngioDynamics, Inc.'s Q2 2018 Earnings (ANGO)
www.americanbankingnews.com - October 2 at 6:52 AM
AngioDynamics, Inc. (ANGO) Given Average Rating of "Hold" by AnalystsAngioDynamics, Inc. (ANGO) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 1 at 7:16 PM
AngioDynamics, Inc. (ANGO) Receives Hold Rating from KeyCorpAngioDynamics, Inc. (ANGO) Receives Hold Rating from KeyCorp
www.americanbankingnews.com - September 29 at 11:08 PM
AngioDynamics, Inc. (ANGO) Posts  Earnings Results, Misses Expectations By $0.04 EPSAngioDynamics, Inc. (ANGO) Posts Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - September 29 at 8:06 AM
Mid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike HigherMid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike Higher
www.benzinga.com - September 28 at 9:28 PM
AngioDynamics misses Street 1Q forecastsAngioDynamics misses Street 1Q forecasts
finance.yahoo.com - September 28 at 12:51 PM
AngioDynamics, Inc. (ANGO) Issues FY18 Earnings GuidanceAngioDynamics, Inc. (ANGO) Issues FY18 Earnings Guidance
www.americanbankingnews.com - September 28 at 9:06 AM
AngioDynamics Reports Fiscal 2018 First Quarter ResultsAngioDynamics Reports Fiscal 2018 First Quarter Results
feeds.benzinga.com - September 28 at 6:59 AM
AngioDynamics misses by $0.04, misses on revenueAngioDynamics misses by $0.04, misses on revenue
seekingalpha.com - September 28 at 6:08 AM
AngioDynamics, Inc. (ANGO) Scheduled to Post Quarterly Earnings on TuesdayAngioDynamics, Inc. (ANGO) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - September 26 at 1:20 AM
AngioDynamics BioFlo Platform Strong, Debt Levels HighAngioDynamics' BioFlo Platform Strong, Debt Levels High
finance.yahoo.com - September 18 at 4:18 PM
AngioDynamics' BioFlo Platform Strong, Debt Levels HighAngioDynamics' BioFlo Platform Strong, Debt Levels High
finance.yahoo.com - September 18 at 4:18 PM
Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ OpenOutcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
finance.yahoo.com - September 14 at 4:26 PM
AngioDynamics to Report Fiscal 2018 First Quarter Financial ResultsAngioDynamics to Report Fiscal 2018 First Quarter Financial Results
feeds.benzinga.com - September 14 at 6:23 AM
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare ConferenceAngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 13 at 5:03 PM
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare ConferenceAngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 13 at 5:03 PM
KeyCorp Reaffirms Hold Rating for AngioDynamics, Inc. (ANGO)KeyCorp Reaffirms Hold Rating for AngioDynamics, Inc. (ANGO)
www.americanbankingnews.com - August 27 at 1:08 PM
AngioDynamics, Inc. (ANGO) Expected to Post Quarterly Sales of $86.07 MillionAngioDynamics, Inc. (ANGO) Expected to Post Quarterly Sales of $86.07 Million
www.americanbankingnews.com - August 23 at 3:24 PM
ETFs with exposure to AngioDynamics, Inc. : August 18, 2017ETFs with exposure to AngioDynamics, Inc. : August 18, 2017
finance.yahoo.com - August 18 at 9:06 PM
AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue?AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue?
finance.yahoo.com - August 18 at 4:03 PM
AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue?AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue?
finance.yahoo.com - August 18 at 4:03 PM
AngioDynamics, Inc. (ANGO) Given Consensus Rating of "Hold" by BrokeragesAngioDynamics, Inc. (ANGO) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 12 at 6:38 PM
AngioDynamics (ANGO) Presents At Canaccord Genuity 37th Annual Growth Conference - SlideshowAngioDynamics (ANGO) Presents At Canaccord Genuity 37th Annual Growth Conference - Slideshow
seekingalpha.com - August 11 at 9:22 PM
AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017
finance.yahoo.com - August 8 at 3:46 PM
AngioDynamics to Present at the 2017 Canaccord Genuity Growth ConferenceAngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
finance.yahoo.com - August 7 at 4:46 PM
AngioDynamics, Inc. (NASDAQ:ANGO) Expected to Announce Quarterly Sales of $86.07 MillionAngioDynamics, Inc. (NASDAQ:ANGO) Expected to Announce Quarterly Sales of $86.07 Million
www.americanbankingnews.com - August 4 at 7:08 AM
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.
finance.yahoo.com - July 27 at 8:40 PM
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGOINVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO
finance.yahoo.com - July 26 at 4:27 PM
Teleflex (TFX) & AngioDynamics (ANGO) Head-To-Head AnalysisTeleflex (TFX) & AngioDynamics (ANGO) Head-To-Head Analysis
www.americanbankingnews.com - July 25 at 4:24 PM
Financial Comparison: AngioDynamics (NASDAQ:ANGO) vs. Teleflex (TFX)Financial Comparison: AngioDynamics (NASDAQ:ANGO) vs. Teleflex (TFX)
www.americanbankingnews.com - July 25 at 8:30 AM

SEC Filings

AngioDynamics (NASDAQ:ANGO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AngioDynamics (NASDAQ:ANGO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AngioDynamics (NASDAQ ANGO) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.